Comparison of Single Port Robotic Donor Nephrectomy and Laparoscopic Donor Nephrectomy.


Journal

Journal of endourology
ISSN: 1557-900X
Titre abrégé: J Endourol
Pays: United States
ID NLM: 8807503

Informations de publication

Date de publication:
07 Jan 2024
Historique:
medline: 8 1 2024
pubmed: 8 1 2024
entrez: 8 1 2024
Statut: aheadofprint

Résumé

To compare the intra-operative and post-operative outcomes of Single-Port Robotic Donor Nephrectomies (SP RDNs) and Laparoscopic Donor Nephrectomies (LDNs) Materials and Methods: We retrospectively reviewed our institutional database for patients who received LDN or SP RDN between September 2020 and December 2022. Donor baseline characteristics, intra-operative outcomes, post-operative outcomes, and recipient renal function were extracted and compared between LDN and SP RDN. SP RDN learning curve analysis based on operative time and graft extraction time was performed using Cumulative Sum Analysis. 144 patients underwent LDN and 32 patients underwent SP RDN. LDN and SP RDN had similar operative times (LDN: 190.3 ± 28.0 min. 194.5 ± 35.1 min., p=0.3253). SP RDN patients had significantly greater extraction times (LDN: 83.2 ± 40.3 sec. 204.1 ± 52.2 sec, p<0.0001) and warm ischemia times (LDN: 145.1 ± 61.7 sec. 275.4 ± 65.6 sec., p<0.0001). There were no differences in patient subjective pain scores, inpatient opioid usage, or Clavien-Dindo II+ complications. Short- and medium-term post-operative donor and recipient renal function were also similar between the groups. SP RDN graft extraction time and total operative time learning curves were achieved at case 27 and 13, respectively. SP RDN is a safe and feasible alternative to LDN that minimizes post-operative abdominal incisional scars and has a short learning curve. Future randomized prospective clinical trials are needed to confirm the findings of this study and to identify other potential benefits and drawbacks of SP RDNs.

Identifiants

pubmed: 38185847
doi: 10.1089/end.2023.0364
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Michael A Palese (MA)

The Mount Sinai Medical Center, Urology, One Gustave L. Levy Place, Box 1272, New York, New York, United States, 10029; michael.palese@mountsinai.org.

Chih Peng Chin (CP)

Icahn School of Medicine at Mount Sinai, Urology, 1 Gustav L Levy Place, New York, New York, United States, 10029; chihpeng.chin@icahn.mssm.edu.

Evan Garden (E)

Icahn School of Medicine at Mount Sinai, Urology, 1 Gustave L. Levy Pl, New York, New York, United States, 10029; Evan.Garden@mountsinai.org.

Benjamin Eilender (B)

Icahn School of Medicine at Mount Sinai, Urology, New York, New York, United States; Benjamin.Eilender@mountsinai.org.

Micah Levy (M)

Icahn School of Medicine at Mount Sinai, 5925, Urology, New York, New York, United States; micah.levy@icahn.mssm.edu.

Krishna Teja Ravivarapu (KT)

Icahn School of Medicine at Mount Sinai, 5925, Urology, New York, New York, United States; krishna.ravivarapu@icahn.mssm.edu.

Daniel Wang (D)

Icahn School of Medicine at Mount Sinai, 5925, Urology, New York, New York, United States; daniel.wang@icahn.mssm.edu.

Hannah Freid (H)

Icahn School of Medicine at Mount Sinai, Urology, New York, New York, United States; hannah.freid@icahn.mssm.edu.

Osama Al-Alao (O)

Icahn School of Medicine at Mount Sinai, Urology, New York, New York, United States; osama.alalao@gmail.com.

Joseph Sewell-Araya (J)

Icahn School of Medicine at Mount Sinai, 5925, Urology, New York, New York, United States; sewelljo@yahoo.com.

Dianne LaPointe-Rudow (D)

Recanati/Miller Transplantation Institute at Mount Sinai, 52100, New York, New York, United States; dianne.lapointerudow@mountsinai.org.

Daniel Herron (D)

Icahn School of Medicine at Mount Sinai, General Surgery, New York, New York, United States; daniel.herron@mountsinai.org.

Edward Chin (E)

Icahn School of Medicine at Mount Sinai, General Surgery, New York, New York, United States; Edward.Chin@mountsinai.org.

Antonios Arvelakis (A)

Recanati/Miller Transplantation Institute at Mount Sinai, 52100, New York, New York, United States; antonios.arvelakis@mountsinai.org.

Ron Shapiro (R)

Recanati/Miller Transplantation Institute at Mount Sinai, 52100, New York, New York, United States; ron.shapiro@mountsinai.org.

Francisca Larenas (F)

Icahn School of Medicine at Mount Sinai, Urology, One Gustave L. Levy Place, New York, New York, United States, 10029; flarenas@uchile.cl.

Sander Florman (S)

Recanati/Miller Transplantation Institute at Mount Sinai, 52100, New York, New York, United States; sander.florman@mountsinai.org.

Classifications MeSH